VTVT News and Press, vTv Therapeutics Inc. From 06/15/20

Edesa Biotech (NASDAQ: EDSA ) +218%  on launch of COVID-19 study in Canada. More news on: Edesa Biotech, Inc., Brickell Biotech, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...

VTv Therapeutics (NASDAQ: VTVT ) is up  45%  premarket on the heels of results from the Phase 2 Simplici-T1 study evaluating TTP399 as an adjunct to insulin therapy in adults with type 1 diabetes. More news on: vTv Therapeutics Inc., Healthcare stocks news, Read m...

As of 5:50 AM, here are the stocks that are up most and down most in early premarket trading. More news on: China HGS Real Estate Inc., vTv Therapeutics Inc., China Natural Resources, Inc., , Stocks on the move, News on ETFs Read more ...

- Treatment with TTP399 resulted in significant improvements in HbA1c with reduction in insulin, without increasing risk of hypoglycemia or diabetic ketoacidosis (DKA) - HIGH POINT, N.C., June 13, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc.  (Nasdaq: VTVT) today made two p...

VTv Therapeutics' (NASDAQ: VTVT ) two late-breaking  abstracts reinforcing the potential of TTP399 as an oral adjunctive therapy in type 1 diabetes will be presented at the American Diabetes Association’s 80th Scientific Sessions, which is being held virtually, June 12 ...

HIGH POINT, N.C., May 27, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc.  (Nasdaq: VTVT) today announced that two late-breaking abstracts reinforcing the potential of TTP399 as an oral adjunctive therapy in type 1 diabetes will be presented virtually at the American Diabetes Associa...

HIGH POINT, N.C., May 22, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that it will host its 2020 Annual Meeting of Stockholders (the "Annual Meeting") as a virtual-only meeting that will be held via live audio webcast due to the public health and safety ...

Gainers: SIFCO Industries (NYSEMKT: SIF ) +94% . More news on: SIFCO Industries, Inc., Creative Realities, Inc., United Natural Foods, Inc., Stocks on the move, , Read more ...

vTv Therapeutics (NASDAQ: VTVT ): Q1 Non-GAAP EPS of -$0.11 misses by $0.01 ; GAAP EPS of -$0.11. More news on: vTv Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HIGH POINT, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent clinical achievements. “In spite of the challenges presented by the COVID-19 pande...